Stem cells are gaining attention for their potential to treat leukemia, certain solid tumor cancers, and inherited metabolic ...
A new form of CAR T kills leukemia, multiple myeloma, and sarcoma in mice, opening the door to a future off-the-shelf cancer treatment without chemotherapy.
Stem cell therapy shows promise for silicosis by targeting fibrosis, immune imbalance, and lung function decline.
Morning Overview on MSN
Japan approves first treatment made from reprogrammed human cells
Japan’s health ministry has endorsed two stem-cell therapies derived from induced pluripotent stem (iPS) cells, making them the first treatments of their kind to clear a national regulatory body ...
Cellular therapies, including TIL, TCR, and CAR-T, are transforming lung cancer care by utilizing personalized immune cells to target tumors. TIL therapy, now FDA-approved for solid tumors, shows ...
Stanford Medicine pediatric hematologist Agnieszka Czechowicz, MD, Ph.D., has devoted her research career to improving ...
Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...
CytoNiche’s 3D FloTrix™ platform won the Emerging Bioprocessing Supplier – Downstream award at ABEA 2026, recognising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results